a manifestation of undetected leukemia present months to years before the manifestations of CLL. However, for the majority of patients in our study, we believe this hypothesis is unlikely. The PLCO population is relatively health-conscious and has volunteered for and complied with the requirements of a screening trial, including annual screening tests and blood collection. This is reflected in the very high proportion of early-stage CLL among patients in our study.
